- Home
- VCRE vs DNTH Comparison
VCRE vs DNTH Comparison
Compare VCRE & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$99.89
Company Overview
Basic Information| Metric | VCRE | DNTH |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | VCRE | DNTH |
|---|---|---|
| Price | $12.00 | $99.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $121.00 |
| AVG Volume (30 Days) | 5.8K | ★ 1.1M |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.05 | $18.08 |
| 52 Week High | $12.77 | $102.37 |
Technical Indicators
Market Signals| Indicator | VCRE | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 61.44 |
| Support Level | N/A | $79.27 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 5.39 |
| MACD | 0.00 | 0.67 |
| Stochastic Oscillator | 0.00 | 82.57 |
Price Performance
Historical Comparison VCRE
DNTH
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.